H-1B sponsorship profile: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Across U.S. Department of Labor LCA disclosures, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC filed 15 Labor Condition Applications covering 15 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (15 certified of 15 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on GlaxoSmithKline Consumer Healthcare Holdings (US) LLC’s H-1B petitions range from $96,305 at the low end to $173,086 at the high end, with a petition-weighted average of $123,716. That range reflects the mix of occupations the company sponsors, led by Technical Project Lead (TPL) & Sr Formulation Scientist (2 petitions at $96,305 avg), followed by Senior Development Scientist, Voltaren and Principal Development Scientist Voltaren. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC is headquartered in Warren, NJ under NAICS code 325412, and places H-1B workers across 5 states, most heavily in VA, NC, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ranks. By H-1B petition volume, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC is #12,524 of 119,880 employers nationally and #1,132 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.